HROW - Harrow Health Inc

https://www.harrow.com

Buy Momentum: Bearish

Recent News

Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030 - Harrow ( NASDAQ:HROW )

Benzinga • 6 days, 19 hours ago • score: 0.19

NASHVILLE, Tenn., Sept. 08, 2025 ( GLOBE NEWSWIRE ) -- Harrow HROW, a leading provider of ophthalmic disease management solutions in North America, today announced the pricing of its private offering ( the "Offering" ) of $250.0 million aggregate principal amount of 8.625% senior unsecured notes ...

Bullish

Surging Earnings Estimates Signal Upside for Harrow ( HROW ) Stock

Zacks Commentary • 1 month ago • score: 0.68

Harrow (HROW) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Bullish

Best Momentum Stock to Buy for August 15th

Zacks Commentary • 1 month ago • score: 0.25

ECG, NVT and HROW made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 15, 2025.

Bullish

Harrow Unusual Options Activity - Harrow ( NASDAQ:HROW )

Benzinga • 1 month ago • score: 0.43

High-rolling investors have positioned themselves bullish on Harrow HROW, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.

52W High

$59.23

52W Low

$20.85

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.33

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

39.84

EV/EBITDA (<8 favorable)

48.19

EV/Revenue (<3 favorable)

6.80

P/S (TTM) (<3 favorable)

6.01

P/B (<3 favorable)

27.56

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

15.72%

Institutions (25–75% balanced)

57.41%

Shares Outstanding

37,002,100

Float

27,229,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

227,661,000

Gross Profit (TTM)

169,754,000

EPS (TTM)

-0.28

Profit Margin (>10% good)

-0.04%

Operating Margin (TTM) (higher better)

0.18%

ROE (TTM) (>15% strong)

-0.19%

EPS YoY (Quarterly) (>10% good)

-0.64

Revenue YoY (Quarterly) (>8% good)

0.30

Momentum

Bearish momentum

Value

1.0840

1.0674

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025